Founderland Logofounderland
the ★ top ★ 100 ★ marketers ★
SavedSearch
FoundersFounders
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Product Launches
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Investment News
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Research & Innovation
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
FoundersFounders
Return

Company Page

MSICS Pharma

Founders

Omer ZerahiaRoei Zerahia

MSICS Pharma is an Israeli biotech company developing medical-grade, naturally-sourced psilocybin for pharmaceutical applications. It holds first-of-its-kind GMP manufacturing licenses from the Israeli Ministry of Health, making it the only company in Israel and Europe authorized to produce psilocybin for medical purposes. Its flagship product, MSX-06, is undergoing Phase II clinical trials for PTSD, Treatment-Resistant Depression (TRD), and OCD in collaboration with leading Israeli hospitals.

Company Founded in 2020

Healthtech & Biotech iconHealthtech & Biotech

Articles about MSICS Pharma

MSICS Pharma Raises $3.6M to Scale Natural Psilocybin Production

MSICS Pharma Raises $3.6M to Scale Natural Psilocybin Production

Healthtech & Biotech iconHealthtech & BiotechMay 10, 2026

About

Dreamwell AIContact UsOur Story

Articles

Product LaunchesInvestment NewsResearch & Innovation

founderland

We Use Cookies

We baked up some cookies – the digital kind. They help Draper run like a well-oiled mid-century machine. Some are essential to the experience, others help us tailor things to your taste. We promise, no crumbs on your blazer. Take a moment to choose what works for you.